Vector VestAdvertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator beambe, BigBake1, LongRun8, TRUTH
Search This Board:
Last Post: 1/30/2015 8:17:02 AM - Followers: 125 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.



ADJUVANT PIPELINE:





CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for NVAX
NVAX News: Amended Statement of Ownership (sc 13g/a) 01/29/2015 02:22:39 PM
NVAX News: Novavax Announces Management Promotion 01/08/2015 04:06:47 PM
NVAX News: Novavax Announces Management Promotion 01/08/2015 04:05:00 PM
NVAX News: Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference 01/07/2015 10:17:17 AM
NVAX News: Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference 01/07/2015 10:08:17 AM
PostSubject
#2096   Blackrock purchase 16 million shares. jcoukr 01/30/15 08:17:02 AM
#2095   There has been a new suspected case of Princes 01/29/15 07:39:41 PM
#2094   NVAX $8 in pre-market, albeit small volume, but LongRun8 01/28/15 08:46:50 AM
#2093   Etablished NEW position Today... SJOGRINGO 01/26/15 03:36:19 PM
#2092   Short here near days high, 7.65. Looking for djsleepy860 01/21/15 11:27:16 AM
#2091   * * $NVAX Video Chart 01-20-15 * * ClayTrader 01/20/15 04:55:29 PM
#2090   NVAX very nice volume and price action past LongRun8 01/20/15 02:10:13 PM
#2089   Wow 21 000 000 at the bell! HandyMan2000 01/16/15 04:18:09 PM
#2088   I have a feeling that breakage through the HandyMan2000 01/16/15 01:45:53 PM
#2087   imo if the 29 000 000 shorts get squeezed HandyMan2000 01/16/15 01:29:22 PM
#2086   Nice NVAX \o/....! MRatt 01/16/15 01:17:21 PM
#2085   250000 blocks going through HandyMan2000 01/16/15 12:48:07 PM
#2084   52 week high within range! HandyMan2000 01/16/15 11:40:06 AM
#2083   It was a great interview, I watched it 1990Flstf 01/15/15 11:28:21 PM
#2082   NVAX CEO was on Mad Money with Jim LongRun8 01/15/15 09:16:01 PM
#2081   Market Hours Last Trade: 6.305 ^ 0.355 (5.97%) TRUTH 01/10/15 05:33:48 AM
#2080   Indeed, decent volume! MRatt 01/09/15 12:43:11 PM
#2079   very nice day here. looking good jcoukr 01/09/15 12:04:44 PM
#2078   Well had he waited he would have made stockboy 01/09/15 12:30:32 AM
#2077   http://www.cbf-1000.de/VBForum/images/misc/LogoForum-happy-2015.png beambe 12/31/14 07:21:40 PM
#2076   I think it might have been rebalancing of LongRun8 12/21/14 05:51:54 PM
#2075   Novavax Director Sells $267,130 in Stock (NVAX) TRUTH 12/21/14 02:16:50 PM
#2074   Something must be coming. 1,113,000 shares traded after-hours.- Jon32 12/21/14 10:09:13 AM
#2073   It was market wide, you can see the BigBake1 12/12/14 08:57:55 AM
#2072   That was an interesting little dip heading into LongRun8 12/11/14 07:39:00 PM
#2071   Well it closed above the gap price of BigBake1 12/11/14 04:03:02 PM
#2070   Hit $6.00 today, just now. LongRun8 12/11/14 12:10:49 PM
#2069   They had me at the summary.... TRUTH 12/11/14 11:30:00 AM
#2068   Looks like some strength going into the $6 BigBake1 12/11/14 10:17:01 AM
#2067   Merck Ebola vaccine trial suspended for checks after underdog150 12/11/14 09:05:59 AM
#2066   Seeking Alpha from this morning underdog150 12/10/14 04:55:50 PM
#2065   Agree!! belgiumsui 12/10/14 12:18:58 PM
#2064   Looks like we retest the $5.80 again, if BigBake1 12/10/14 10:00:26 AM
#2063   Analyst Update on Short Term Price Target:, Novavax Inc TRUTH 12/10/14 09:52:44 AM
#2062   Analyst Consensus: Novavax Inc-Excerpt TRUTH 12/05/14 09:08:40 AM
#2061   NVAX mentioned in Bloomberg report underdog150 12/02/14 07:50:56 PM
#2060   Great day, in NVAX world! Big buy at MRatt 11/27/14 05:14:38 AM
#2059   10usd @ end of year... belgiumsui 11/26/14 02:26:12 PM
#2056   Indeed! Great to be in! Think big, $NVAX MRatt 11/20/14 12:38:04 PM
#2055   Very good things happening here for NVAX. LongRun8 11/20/14 11:34:22 AM
#2054   It needs to gain some traction here, slipping BigBake1 11/20/14 10:05:08 AM
#2053   The FDA and Market have both spoken. ;-) TRUTH 11/20/14 09:18:54 AM
#2052   Weeeeeeee!! belgiumsui 11/20/14 09:15:52 AM
#2051   U.S. FDA Grants Fast Track Designation to Novavax' underdog150 11/20/14 08:46:12 AM
#2050   http://investors.morningstar.com/ownership/shareholders-overview.html?t=NVAX&reg belgiumsui 11/14/14 10:45:55 AM
#2049   Over valued? Not the slightest, BARDA doesnt give BigBake1 11/11/14 08:09:19 AM
#2048   The stock has its "ups and downs" but TRUTH 11/11/14 05:22:40 AM
#2047   I think this will pullback eventually because its ATCrunch 11/11/14 01:03:34 AM
#2046   $NVAX DD Notes ~ http://www.ddnotesmaker.com/NVAX stocktrademan 11/10/14 12:08:56 PM
#2044   A sense of wonderment has fallen upon me. Footerman 11/09/14 09:45:51 PM
PostSubject